ProgrammableMarketing/cordis.com (opens in a new tab)
PDF

Views

  • Plan
  • Roadmap
  • Research

On this page

  • The brief
  • Start here
  • Idea portfolio
  • Effort vs impact
  • This week · 6
  • This quarter · 9
  • Big bets · 3
  • Wildcards · 3
Generated Oct 21, 2026
  1. Programmable
  2. Playbooks
  3. Cordis
Cordis logo

growth playbook · Oct 21, 2026

cordis.com (opens in a new tab)

Cordis growth playbook

Diagnosis

Cordis has its biggest launch in years: SELUTION SLR is the first sirolimus drug-eluting balloon approved in the U.S., with more trials and a peripheral version behind it, and it is hiring product marketing, medical education, digital and field roles to sell it. The website has not caught up.

The only case studies are template pages showing other companies' devices, the events page is empty, product pages share one boilerplate description and the root domain is a country list. This playbook fixes those first, then gives the launch a case library, an evidence hub, a VAC pack, fast lead routing, an online DEB module and analytics that tie education to adoption.

Growth Score

6/10

Biggest Opportunity

Make cordis.com the place U.S. physicians and hospital committees go to evaluate drug-eluting balloons: real cases, clear trial pages, a VAC pack and online education.

Biggest Risk

Boston Scientific's AGENT DCB, the device Cordis benchmarks against, already competes for the same coronary cases, and Shockwave Medical specializes in IVL. A slow or inconsistent launch lets rivals set the standard for how physicians use drug-coated balloons.

01

Start here

The three moves to make first. Each one is written up in full below.

  1. 1

    Replace the four "Case Study Example" placeholder pages with real SELUTION SLR in-stent restenosis cases

    Unpublish the four Case Study Example pages and redirect them to the SELUTION SLR page.

    High impact First result in 1 month
  2. 2

    Write a real search description for SELUTION SLR and every product page

    Rewrite the SELUTION SLR description today.

    Medium impact First result in 1 month
  3. 3

    Fix the empty Events page so congress and course pages can be found

    Check why the listing filter returns no results.

    Medium impact First result in 2 weeks

02

Your idea portfolio

21 ideas, grouped by when to run them. Open any idea for how to run it: the steps, who to approach, copy you can use, and how to measure it.

  • 7 ideas are marked Unexpected: plays you are unlikely to have tried.

Every idea placed by the effort it takes against the impact it could have. Quick wins sit top left; select a number to open that idea. The filters below narrow the list by status, timing, category and what Programmable can build.

Effort vs impactEach number is an idea. Select one to open it.
Impact →
Quick wins · 3Big bets · 8Fill-ins · 7Reconsider · 3
Effort →

Showing 21 of 21 ideas

This week 6

Quick wins with a clear first action.

  • 01

    The only case studies on cordis.com are four 2022 template pages, still live and in the sitemap, telling one coronary case built around the GuideLiner catheter, a Promus stent and a Sprinter balloon, none of them Cordis products, under "Lorem Ipsum Header" subheadings and a Lorem ipsum disclaimer. SELUTION SLR has just become the first and only sirolimus drug-eluting balloon approved in the U.S. for ISR, and interventional cardiologists evaluating it will look for exactly this: real cases.

    High impactLow effort First result in 1 month Senior Manager

    First action

    Unpublish the four Case Study Example pages and redirect them to the SELUTION SLR page.

    How to measure it

    Information requests from case pages

    Now
    –
    Target
    40 a month
    By
    90 days

    Steps

    1. 1

      Remove placeholders

      Unpublish, drop from the sitemap, redirect.

      Specialist II Digital Marketing 1 day

    2. 2

      Pick cases

      Three to five ISR cases with images and consent.

      Manager, Medical Education 2 weeks

    3. 3

      Write them

      Presentation, technique, result, follow-up.

      Senior Manager, Product Marketing 2 weeks

    4. 4

      Review

      On-label and claims check.

      Regulatory Affairs and Legal 1 week

    5. 5

      Publish

      Case library template linked from the product page.

      Specialist II Digital Marketing 2 days

    6. 6

      Use in the field

      Cases in rep follow-up emails.

      Territory Manager ongoing

    7. 7

      Measure

      Visits and requests per case.

      Specialist II Digital Marketing monthly

    First result
    1 month
    Cost
    Staff time and physician honoraria under existing policy
    Owner
    Senior Manager, Product Marketing

    Smallest test

    Take the placeholders down and publish one real case.

    Why it works

    Take the four placeholders down today (remove from the sitemap and redirect to the SELUTION page). Then publish a case library built on the same URL pattern: three to five ISR cases from SELUTION4ISR investigators or early U.S. users, each with presentation, angiography, device sizing, result and follow-up, reviewed by Medical Affairs and Regulatory as on-label. Link it from the SELUTION product page, the TCT page and the field team's follow-up emails.

    Physicians adopt a new device class through peer cases. The placeholders currently show competitors' devices under the Cordis brand; real cases turn the same pages into launch proof for the product marketing and medical education teams being hired now.

    Ready to use

    ChecklistSELUTION case page template

    [ ] Patient presentation (de-identified)
    [ ] Lesion and prior stent history
    [ ] Device and sizing
    [ ] Technique notes
    [ ] Result and follow-up
    [ ] Physician quote and disclosure
    [ ] Indication and important safety information
    [ ] Link to trial data and IFU
    [ ] Request Additional Information form

    Risks and how to handle them

    • Case selection looks promotional

      Medical Affairs chooses cases; include balanced outcomes and safety information.

    • Image consent

      Use de-identified images with documented consent.

    Evidence

    • Your websiteFour pages titled "Case Study Example 1" to "Case Study Example 4" (published 2022) are live and listed in the sitemap under /na/case-studies/. Each tells the same coronary case "made possible by the GuideLiner catheter", naming other devices Cordis does not sell (a Promus stent, a Sprinter balloon), with "Lorem Ipsum Header" subheadings, a Lorem ipsum disclaimer and a "Back to Radianz Home" link. They are the only case studies on the site.Source
    • Your websiteFDA approval news (September 21, 2026): SELUTION SLR DEB is approved for coronary in-stent restenosis (ISR) and is "the first and only sirolimus drug-eluting balloon approved in the United States". SELUTION4ISR enrolled more than 400 patients at 48 sites; "nearly 1 million" PCIs a year in the U.S., about 10% for ISR; SELUTION4DeNovo (960 patients, small vessels) has completed enrollment. Cordis introduced the first sirolimus drug-eluting stent in the U.S. in 2003.Source
    • HiringSenior Manager, Product Marketing (remote, posted October 1, 2026): translate "approved clinical evidence into clear, differentiated commercial positioning", create "evidence summaries, data-driven messaging tools, congress materials, field-facing resources", lead symposia and congress programs, and support the field with "objection handling, and competitive response materials".Source
    • HiringMedical education hiring: a Manager, Medical Education (posted October 16, 2026) to run "workshops, proctoring pathways, virtual learning, symposia" and track programs with "defined KPIs"; a Senior Manager, Medical Education to "Create the universal framework for program analytics", "Develop end to end strategy supporting Medical Education digital marketing" and build faculty "for future technologies (IVL, Carotid, Peripheral) from pre-launch to post market".Source
  • 02

    Product pages, including SELUTION SLR, share the same company boilerplate meta description, so a search for the product shows "Cordis is a global leader..." rather than what it is. The pages also lack canonical tags.

    Medium impactLow effort First result in 1 month Specialist II Digital Marketi…

    First action

    Rewrite the SELUTION SLR description today.

    How to measure it

    Product page click-through from search

    Now
    –
    Target
    +20%
    By
    90 days

    Steps

    1. 1

      List pages

      All product and portfolio pages.

      Specialist II Digital Marketing 1 day

    2. 2

      Draft

      One description each.

      Senior Manager, Product Marketing 1 week

    3. 3

      Review

      Approved claims only.

      Regulatory Affairs and Legal 1 week

    4. 4

      Publish

      Descriptions and canonicals.

      Specialist II Digital Marketing 2 days

    5. 5

      Check

      Search Console snippets.

      Specialist II Digital Marketing 2 weeks

    6. 6

      Repeat

      For each launch.

      Specialist II Digital Marketing per launch

    First result
    1 month
    Cost
    $0
    Owner
    Specialist II Digital Marketing

    Smallest test

    Change the SELUTION SLR description and watch its search snippet.

    Why it works

    Write a unique description per product (what it is, indication, key differentiator in approved language), starting with SELUTION SLR, MYNX CONTROL and the radial portfolio. Add self-canonical tags across /na/.

    Searchers and AI assistants summarize pages from these fields. A launch product should describe itself in search.

    Risks and how to handle them

    • Claims in snippets

      Use only approved indication wording.

    Evidence

    • Your websiteSELUTION SLR PTCA product page: MicroReservoir and phospholipid coating explained, "36% less force to deliver compared to AGENT DCB" (Cordis 2025 data on file), a sortable SKU table, and links for questions, reimbursement, trials and education. Its meta description is the same company boilerplate used across the site ("Cordis is a global leader in delivering innovative, differentiated cardiovascular and endovascular devices...") and the page has no canonical tag.Source
    • Your websitecordis.com itself is a country picker titled "Welcome to Cordis" with about 200 country links and no product or company content; the North America home is at /na/home and has no canonical tag. Google PageSpeed names the country list as the page's layout-shift element.Source
    • HiringSpecialist II Digital Marketing (remote, posted October 1, 2026): "Build, update, and maintain webpages and landing pages", produce social, display and email creative, do "routine HTML/CSS edits", and use "approved AI-enabled creative tools".Source
  • 03

    The Events page says "Sorry no results found" while 33 event pages exist, from VIVA and TCT to carotid stenting courses and a webinar. Physicians looking for Cordis courses find nothing.

    Medium impactLow effort First result in 2 weeks Manager

    First action

    Check why the listing filter returns no results.

    How to measure it

    Registrations from the events page

    Now
    –
    Target
    +50%
    By
    90 days

    Steps

    1. 1

      Diagnose

      Filter and region settings.

      Specialist II Digital Marketing 1 day

    2. 2

      Fix

      Listing shows upcoming events.

      Specialist II Digital Marketing 2 days

    3. 3

      Archive

      Past events to a separate tab.

      Specialist II Digital Marketing 1 day

    4. 4

      Add courses

      MYNX and LUMEN entries.

      Manager, Medical Education 2 days

    5. 5

      One form

      Same registration path.

      Specialist II Digital Marketing 1 week

    6. 6

      Track

      Registrations by event.

      Senior Manager, Medical Education monthly

    First result
    2 weeks
    Cost
    $0
    Owner
    Manager, Medical Education

    Smallest test

    Fix the filter and list the next three events.

    Why it works

    Repair the event listing filter, show upcoming congresses and courses first, archive past events, and add MYNX Elevate, MYNX Masters and LUMEN to the same listing with one registration path.

    Education is how physicians and lab staff meet a new device. A working calendar turns existing pages into registrations.

    Risks and how to handle them

    • Outdated entries

      Auto-archive by event date.

    Evidence

    • Your websiteThe Events page shows "Sorry no results found", while the sitemap lists 33 event pages (VIVA 2026, TCT 2026, SCAI, SIR, CRT, Charing Cross, a webinar and courses such as carotid stenting and atherosclerosis).Source
    • Your websiteMedical Education page: hands-on MYNX Elevate and MYNX Masters courses for cath and EP lab staff ("up to 4 CE credits"), each with "Request Additional Information", and LUMEN BY CORDIS, an online learning platform "currently available to US based physicians only".Source
    • Your websiteTCT 2026 page: "Welcome to the Limus Era", "The Drug. The Data. The Delivery.", a symposium "Delivering Limus Differently", a reception, and a "Next-Generation DEB Decision Lab", "an interactive, case-based experience focused on the key clinical and technical decision points in DEB therapy". The call to action is "Request Additional Information".Source
  • 04

    Hospitals add a new device class through value analysis committees. Cordis already has the pieces in separate places: reimbursement and coding guides, a Patient Access Program, trial data, the Premier innovation recognition and global use in more than 250,000 patients.

    High impactMedium effort First result in 1 quarter Senior Manager

    First action

    List what three recent VACs asked for.

    How to measure it

    VAC approvals

    Now
    –
    Target
    +30% faster
    By
    2 quarters

    Steps

    1. 1

      Ask the field

      What committees request.

      Territory Manager 1 week

    2. 2

      Assemble

      Evidence, coding, SKUs, contacts.

      Senior Manager, Product Marketing 2 weeks

    3. 3

      Review

      Claims and economics wording.

      Regulatory Affairs and Legal 2 weeks

    4. 4

      Publish

      Gated page for hospital staff.

      Specialist II Digital Marketing 1 week

    5. 5

      Train

      How to use it.

      Senior Sales Trainer 1 week

    6. 6

      Track

      Time from request to approval.

      Senior Manager, Strategic Initiatives monthly

    First result
    1 quarter
    Cost
    Staff time only
    Owner
    Senior Manager, Product Marketing

    Smallest test

    Send a draft pack to one committee.

    Why it works

    Bundle them into one downloadable VAC pack and a short page: indication, evidence summary, coding guide, economic considerations, ordering SKUs, and contacts. Give territory managers a version they can send ahead of each committee meeting.

    A complete pack shortens the time from physician interest to a hospital purchase order, which decides launch speed.

    Risks and how to handle them

    • Economic claims

      Use payer-neutral, reviewed language.

    Evidence

    • Your websiteSELUTION SLR reimbursement page: coding and payment guidance, two downloadable coding guides, a Reimbursement Support Team phone line, and a Cordis Patient Access Program offering benefits verification and prior authorization support.Source
    • Your websiteNews (September 28, 2026): Cordis is honored at Premier's Supplier Innovation Celebration; SELUTION SLR DEB "is commercially available in more than 65 countries and has been used to treat more than 250,000 patients worldwide". A 2024 release announced a Premier agreement for the MYNX CONTROL VENOUS closure device.Source
    • Your websiteFDA approval news (September 21, 2026): SELUTION SLR DEB is approved for coronary in-stent restenosis (ISR) and is "the first and only sirolimus drug-eluting balloon approved in the United States". SELUTION4ISR enrolled more than 400 patients at 48 sites; "nearly 1 million" PCIs a year in the U.S., about 10% for ISR; SELUTION4DeNovo (960 patients, small vessels) has completed enrollment. Cordis introduced the first sirolimus drug-eluting stent in the U.S. in 2003.Source
    • Your websiteSELUTION SLR PTCA product page: MicroReservoir and phospholipid coating explained, "36% less force to deliver compared to AGENT DCB" (Cordis 2025 data on file), a sortable SKU table, and links for questions, reimbursement, trials and education. Its meta description is the same company boilerplate used across the site ("Cordis is a global leader in delivering innovative, differentiated cardiovascular and endovascular devices...") and the page has no canonical tag.Source
  • 05

    The TCT page, product pages and courses all end in "Request Additional Information", and Cordis is hiring territory managers and clinical sales specialists across the Southeast and New York. A request is only useful if the local team calls fast.

    High impactLow effort First result in 1 month Territory Manager

    First action

    Measure today's time from form to first contact.

    How to measure it

    One-day follow-up rate

    Now
    –
    Target
    90%
    By
    60 days

    Steps

    1. 1

      Measure

      Current response time.

      Senior Manager, Strategic Initiatives 2 days

    2. 2

      Add fields

      Specialty, hospital, ZIP.

      Specialist II Digital Marketing 2 days

    3. 3

      Route

      Territory mapping in HubSpot.

      Specialist II Digital Marketing 1 week

    4. 4

      Alert

      TM and CSS notifications.

      Specialist II Digital Marketing 2 days

    5. 5

      Follow up

      With a relevant case.

      Clinical Sales Specialist ongoing

    6. 6

      Review

      Weekly in sales meetings.

      Regional Sales Director weekly

    First result
    1 month
    Cost
    Staff time only
    Owner
    Territory Manager

    Smallest test

    Route one week of requests by hand and time the responses.

    Why it works

    Add specialty, hospital and ZIP to the HubSpot form, route by territory, alert the TM and CSS, and set a one-business-day follow-up rule with a case or VAC pack attached.

    Fast, specific follow-up is the cheapest way to convert launch interest into evaluations.

    Risks and how to handle them

    • Territory gaps while hiring

      Route open territories to the regional director.

    Evidence

    • Your websiteTCT 2026 page: "Welcome to the Limus Era", "The Drug. The Data. The Delivery.", a symposium "Delivering Limus Differently", a reception, and a "Next-Generation DEB Decision Lab", "an interactive, case-based experience focused on the key clinical and technical decision points in DEB therapy". The call to action is "Request Additional Information".Source
    • HiringU.S. field hiring since September 21, 2026: Territory Managers (Syracuse, Albany, Northwest Atlanta, Memphis) for "Cold calling, prospecting"; Clinical Sales Specialists (Columbia SC, Greenville/Spartanburg, Sarasota, Chattanooga) focused on "the cultivation of new physician users and re-engaging lost customers"; and a Senior Sales Trainer for "new product introductions, portfolio expansions".Source
    • HiringSpecialist II Digital Marketing (remote, posted October 1, 2026): "Build, update, and maintain webpages and landing pages", produce social, display and email creative, do "routine HTML/CSS edits", and use "approved AI-enabled creative tools".Source
  • 06

    The sitemap lists video categories called "video-category-1", "movies" (titled in Japanese) and "product-movis", a news URL ending "new-press-release", and a news headline with "SELUTON". Small errors on a medical device site cost credibility with clinicians and procurement.

    Medium impactLow effort First result in 1 week Specialist II Digital Marketi…

    First action

    Fix the SELUTON typo today.

    How to measure it

    Test pages in the sitemap

    Now
    –
    Target
    0
    By
    30 days

    Steps

    1. 1

      List

      All test and placeholder pages.

      Specialist II Digital Marketing 1 day

    2. 2

      Fix or remove

      With redirects.

      Specialist II Digital Marketing 1 day

    3. 3

      Move

      Japanese content to its region.

      Specialist II Digital Marketing 1 day

    4. 4

      Checklist

      Before publishing.

      Specialist II Digital Marketing 1 day

    5. 5

      Audit

      Quarterly.

      Specialist II Digital Marketing quarterly

    6. 6

      Report

      To marketing leadership.

      Senior Manager, Product Marketing quarterly

    First result
    1 week
    Cost
    $0
    Owner
    Specialist II Digital Marketing

    Smallest test

    Fix the typo and rename one category.

    Why it works

    Rename or remove the test categories, move the Japanese page to the Japan site, fix the typo and the slug (with a redirect), and add a pre-publish checklist for the web team.

    Clean pages support trust and keep search engines focused on the pages that matter.

    Risks and how to handle them

    • Broken links

      Redirect every removed URL.

    Evidence

    • Your websiteSitemap (209 URLs, checked October 20, 2026): video category pages named "video-category-1", "movies" (titled in Japanese, 動画で見る) and "product-movis"; a news URL ending "new-press-release" (the MedAlliance acquisition); the news list headline "Cordis Unveils Positive Results for Two SELUTON SLR DEB Trials"; most product pages last changed in 2021 to 2024.Source
    • Your websiteFour pages titled "Case Study Example 1" to "Case Study Example 4" (published 2022) are live and listed in the sitemap under /na/case-studies/. Each tells the same coronary case "made possible by the GuideLiner catheter", naming other devices Cordis does not sell (a Promus stent, a Sprinter balloon), with "Lorem Ipsum Header" subheadings, a Lorem ipsum disclaimer and a "Back to Radianz Home" link. They are the only case studies on the site.Source

This quarter 9

The core plays for the next three months.

  • 07

    Cordis has a growing drug-eluting balloon program (SELUTION4ISR, SELUTION DeNovo, SELUTION4SFA, a 10,000-patient registry) shown as a dense table. The product marketing role is hired to turn approved evidence into "evidence summaries" and "data-driven messaging tools".

    High impactMedium effort First result in 1 quarter Senior Manager

    First action

    Draft the SELUTION4ISR page first.

    How to measure it

    Trial page visits

    Now
    –
    Target
    3,000 a month
    By
    2 quarters

    Steps

    1. 1

      Template

      Standard trial page.

      Senior Manager, Product Marketing 1 week

    2. 2

      Draft

      ISR, DeNovo, SFA, registry.

      Senior Manager, Product Marketing 1 month

    3. 3

      Review

      Medical and regulatory status labels.

      Regulatory Affairs and Legal 1 month

    4. 4

      Publish

      With alert sign-up.

      Specialist II Digital Marketing 1 week

    5. 5

      Field PDF

      One-page summaries.

      Senior Manager, Product Marketing 2 weeks

    6. 6

      Update

      After each congress.

      Senior Manager, Product Marketing per congress

    First result
    1 quarter
    Cost
    Staff time only
    Owner
    Senior Manager, Product Marketing

    Smallest test

    Publish one trial page.

    Why it works

    Give each trial its own page: question, design, patients, endpoints, results, publication and ClinicalTrials.gov link, labeled by U.S. approval status. Add a one-page summary PDF for the field and an alert sign-up for new data.

    Physicians, journalists and AI assistants cite structured trial pages, and a single source keeps field messaging consistent.

    Risks and how to handle them

    • Off-label perception

      Label each trial by indication and approval status.

    Evidence

    • Your websiteClinical information page for drug-eluting balloons: a trial table (indication, patients, region, design, status, ClinicalTrials.gov number, results), for example SELUTION4SFA, 300 patients, 2:1 RCT DEB vs PTA, NCT05132361. News from May 2025: a global coronary registry for SELUTION SLR "will enroll up to 10,000 patients worldwide".Source
    • Your websiteFDA approval news (September 21, 2026): SELUTION SLR DEB is approved for coronary in-stent restenosis (ISR) and is "the first and only sirolimus drug-eluting balloon approved in the United States". SELUTION4ISR enrolled more than 400 patients at 48 sites; "nearly 1 million" PCIs a year in the U.S., about 10% for ISR; SELUTION4DeNovo (960 patients, small vessels) has completed enrollment. Cordis introduced the first sirolimus drug-eluting stent in the U.S. in 2003.Source
    • Your websiteNews (October 6, 2026): SELUTION SLR SUSTANE PTA DEB reached 90.3% 12-month primary patency in the 300-patient SELUTION4SFA U.S. pivotal trial, presented at VIVA 2026; the trial "supports the SUSTANE DEB FDA submission".Source
    • HiringSenior Manager, Product Marketing (remote, posted October 1, 2026): translate "approved clinical evidence into clear, differentiated commercial positioning", create "evidence summaries, data-driven messaging tools, congress materials, field-facing resources", lead symposia and congress programs, and support the field with "objection handling, and competitive response materials".Source
  • 08

    The DEB Decision Lab is a case-based experience on the decision points in DEB therapy, built for one congress. Most U.S. interventional cardiologists will not attend it, and LUMEN BY CORDIS already exists for U.S. physicians.

    High impactMedium effort First result in 1 quarter Senior Manager

    First action

    Get faculty agreement to record the cases.

    How to measure it

    LUMEN DEB module completions

    Now
    –
    Target
    500
    By
    2 quarters

    Steps

    1. 1

      Agree content

      Faculty and Medical Affairs.

      Senior Manager, Medical Education 2 weeks

    2. 2

      Record

      Cases and commentary.

      Manager, Medical Education 1 month

    3. 3

      Build

      Interactive module.

      Manager, Medical Education 1 month

    4. 4

      Review

      Compliance.

      Regulatory Affairs and Legal 2 weeks

    5. 5

      Invite

      From request lists.

      Specialist II Digital Marketing 1 week

    6. 6

      Measure

      Completions by account.

      Senior Manager, Medical Education monthly

    First result
    1 quarter
    Cost
    Faculty and production costs
    Owner
    Senior Manager, Medical Education

    Smallest test

    Publish one recorded case.

    Why it works

    Record the cases and decision points, build an interactive LUMEN module (lesion preparation, sizing, when to use a DEB), and invite physicians from every request and event list. Track completions by account.

    Congress content usually ends when the booth closes. An online version keeps educating through the launch year at almost no extra cost.

    Risks and how to handle them

    • Low completion

      Keep modules under 20 minutes.

    Evidence

    • Your websiteTCT 2026 page: "Welcome to the Limus Era", "The Drug. The Data. The Delivery.", a symposium "Delivering Limus Differently", a reception, and a "Next-Generation DEB Decision Lab", "an interactive, case-based experience focused on the key clinical and technical decision points in DEB therapy". The call to action is "Request Additional Information".Source
    • Your websiteMedical Education page: hands-on MYNX Elevate and MYNX Masters courses for cath and EP lab staff ("up to 4 CE credits"), each with "Request Additional Information", and LUMEN BY CORDIS, an online learning platform "currently available to US based physicians only".Source
    • HiringMedical education hiring: a Manager, Medical Education (posted October 16, 2026) to run "workshops, proctoring pathways, virtual learning, symposia" and track programs with "defined KPIs"; a Senior Manager, Medical Education to "Create the universal framework for program analytics", "Develop end to end strategy supporting Medical Education digital marketing" and build faculty "for future technologies (IVL, Carotid, Peripheral) from pre-launch to post market".Source
  • 09

    The Senior Manager, Medical Education is asked to create "the universal framework for program analytics". Without a link to sales data, courses are measured by attendance rather than by devices adopted.

    High impactMedium effort First result in 2 quarters Senior Manager

    First action

    Match one quarter's attendees to accounts.

    How to measure it

    Trained accounts ordering within 90 days

    Now
    –
    Target
    +25%
    By
    3 quarters

    Steps

    1. 1

      Define

      Matching rules and privacy.

      Senior Manager, Medical Education 2 weeks

    2. 2

      Match

      Attendees to accounts.

      Applications Developer II, AI & Automation 1 month

    3. 3

      Report

      Orders after training.

      Senior Manager, Strategic Initiatives 1 month

    4. 4

      Share

      With territory teams.

      Senior Manager, Medical Education monthly

    5. 5

      Follow up

      With attendees.

      Territory Manager ongoing

    6. 6

      Adjust

      Programs by results.

      Senior Manager, Medical Education quarterly

    First result
    2 quarters
    Cost
    Staff time only
    Owner
    Senior Manager, Medical Education

    Smallest test

    Run the match for one course.

    Why it works

    Match course and LUMEN participants to accounts, then report first orders and repeat use within 90 days for trained versus untrained accounts. Share it with territory managers so they follow up with recent attendees.

    It shows which programs drive adoption and where to invest education spend.

    Risks and how to handle them

    • Compliance concerns

      Keep education separate from sales targets; use aggregate reporting.

    Evidence

    • HiringMedical education hiring: a Manager, Medical Education (posted October 16, 2026) to run "workshops, proctoring pathways, virtual learning, symposia" and track programs with "defined KPIs"; a Senior Manager, Medical Education to "Create the universal framework for program analytics", "Develop end to end strategy supporting Medical Education digital marketing" and build faculty "for future technologies (IVL, Carotid, Peripheral) from pre-launch to post market".Source
    • HiringU.S. field hiring since September 21, 2026: Territory Managers (Syracuse, Albany, Northwest Atlanta, Memphis) for "Cold calling, prospecting"; Clinical Sales Specialists (Columbia SC, Greenville/Spartanburg, Sarasota, Chattanooga) focused on "the cultivation of new physician users and re-engaging lost customers"; and a Senior Sales Trainer for "new product introductions, portfolio expansions".Source
    • Your websiteMedical Education page: hands-on MYNX Elevate and MYNX Masters courses for cath and EP lab staff ("up to 4 CE credits"), each with "Request Additional Information", and LUMEN BY CORDIS, an online learning platform "currently available to US based physicians only".Source
  • 10

    Cordis is hiring territory managers and clinical sales specialists across several regions at the same time as the coronary DEB launch, and a Senior Sales Trainer for "new product introductions".

    High impactMedium effort First result in 1 quarter Senior Sales Trainer

    First action

    Write the certification outline.

    How to measure it

    Certified within 60 days

    Now
    –
    Target
    100%
    By
    2 quarters

    Steps

    1. 1

      Outline

      Modules and assessment.

      Senior Sales Trainer 1 week

    2. 2

      Build

      Content and role-play.

      Senior Sales Trainer 1 month

    3. 3

      Review

      On-label check.

      Regulatory Affairs and Legal 2 weeks

    4. 4

      Pilot

      With the newest hires.

      Senior Sales Trainer 1 month

    5. 5

      Certify

      All new field staff.

      Senior Sales Trainer ongoing

    6. 6

      Refresh

      With new data.

      Senior Manager, Product Marketing quarterly

    First result
    1 quarter
    Cost
    Trainer time
    Owner
    Senior Sales Trainer

    Smallest test

    Certify the next two hires.

    Why it works

    Build a launch certification: indication and evidence, case selection, technique, objection handling, reimbursement and VAC pack, with a proctored case before solo coverage. New hires certify within 60 days.

    Consistent, on-label conversations in every territory protect the launch and speed up new reps.

    Risks and how to handle them

    • Time away from the field

      Use short virtual modules.

    Evidence

    • HiringU.S. field hiring since September 21, 2026: Territory Managers (Syracuse, Albany, Northwest Atlanta, Memphis) for "Cold calling, prospecting"; Clinical Sales Specialists (Columbia SC, Greenville/Spartanburg, Sarasota, Chattanooga) focused on "the cultivation of new physician users and re-engaging lost customers"; and a Senior Sales Trainer for "new product introductions, portfolio expansions".Source
    • HiringSenior Manager, Product Marketing (remote, posted October 1, 2026): translate "approved clinical evidence into clear, differentiated commercial positioning", create "evidence summaries, data-driven messaging tools, congress materials, field-facing resources", lead symposia and congress programs, and support the field with "objection handling, and competitive response materials".Source
    • Your websiteSELUTION SLR reimbursement page: coding and payment guidance, two downloadable coding guides, a Reimbursement Support Team phone line, and a Cordis Patient Access Program offering benefits verification and prior authorization support.Source
  • 11

    Clinical sales specialists are asked to focus on "re-engaging lost customers". Closure devices such as MYNX are reordered often, so a drop in orders is an early sign of a lost account.

    High impactLow effort First result in 1 quarter Clinical Sales Specialist

    First action

    Pull last quarter's order drops.

    How to measure it

    Accounts back to prior volume

    Now
    –
    Target
    30%
    By
    2 quarters

    Steps

    1. 1

      Define drop

      Threshold by product line.

      Senior Manager, Strategic Initiatives 1 week

    2. 2

      Build list

      Weekly report.

      Applications Developer II, AI & Automation 2 weeks

    3. 3

      Assign

      To CSS and TM.

      Regional Sales Director weekly

    4. 4

      Re-engage

      In-service or course.

      Clinical Sales Specialist ongoing

    5. 5

      Log reasons

      Why accounts left.

      Clinical Sales Specialist ongoing

    6. 6

      Review

      Win-back rate.

      Senior Manager, Strategic Initiatives monthly

    First result
    1 quarter
    Cost
    Staff time only
    Owner
    Clinical Sales Specialist

    Smallest test

    Call the ten largest order drops.

    Why it works

    Flag accounts whose closure or catheter orders fell more than a set share over 90 days, give each CSS a weekly list with the last contact and reason, and pair re-engagement with an in-service or MYNX Elevate course.

    Winning back a known account is cheaper than opening a new one.

    Risks and how to handle them

    • Data noise

      Exclude stocking and contract changes.

    Evidence

    • HiringU.S. field hiring since September 21, 2026: Territory Managers (Syracuse, Albany, Northwest Atlanta, Memphis) for "Cold calling, prospecting"; Clinical Sales Specialists (Columbia SC, Greenville/Spartanburg, Sarasota, Chattanooga) focused on "the cultivation of new physician users and re-engaging lost customers"; and a Senior Sales Trainer for "new product introductions, portfolio expansions".Source
    • Your websiteMedical Education page: hands-on MYNX Elevate and MYNX Masters courses for cath and EP lab staff ("up to 4 CE credits"), each with "Request Additional Information", and LUMEN BY CORDIS, an online learning platform "currently available to US based physicians only".Source
    • Your websiteNews (September 28, 2026): Cordis is honored at Premier's Supplier Innovation Celebration; SELUTION SLR DEB "is commercially available in more than 65 countries and has been used to treat more than 250,000 patients worldwide". A 2024 release announced a Premier agreement for the MYNX CONTROL VENOUS closure device.Source
  • 12

    Revenue Operations is hiring a rebate analyst to find "missed obligations, and potential rebate leakage". The same contract data shows which GPO and IDN members buy below their committed tiers.

    Medium impactMedium effort First result in 2 quarters Sr Analyst

    First action

    Run the tier comparison for one GPO contract.

    How to measure it

    Under-tier members moved up a tier

    Now
    –
    Target
    15%
    By
    3 quarters

    Steps

    1. 1

      Map contracts

      Tiers by product.

      Sr Analyst, Rebates Execution 1 month

    2. 2

      Compare

      Purchases vs tiers.

      Sr Analyst, Rebates Execution 2 weeks

    3. 3

      Share

      With territory teams.

      Senior Manager, Strategic Initiatives monthly

    4. 4

      Call

      Under-tier accounts.

      Territory Manager ongoing

    5. 5

      Track

      Tier movement.

      Sr Analyst, Rebates Execution monthly

    6. 6

      Report

      Leakage and growth.

      Sr Analyst, Rebates Execution quarterly

    First result
    2 quarters
    Cost
    Analyst time
    Owner
    Sr Analyst, Rebates Execution

    Smallest test

    Compare one contract this month.

    Why it works

    Each month, list members under their contract tier for each product line and send them to the territory team as growth opportunities, alongside the leakage report.

    It turns a finance control into a sales list with a clear reason to call.

    Risks and how to handle them

    • Contract confidentiality

      Share only account-level guidance with the field.

    Evidence

    • HiringSr Analyst, Rebates Execution (remote, posted September 28, 2026), in Revenue Operations: owns rebate contracts end to end in JD Edwards and leads audits to find "errors, financial risk, missed obligations, and potential rebate leakage".Source
    • Your websiteNews (September 28, 2026): Cordis is honored at Premier's Supplier Innovation Celebration; SELUTION SLR DEB "is commercially available in more than 65 countries and has been used to treat more than 250,000 patients worldwide". A 2024 release announced a Premier agreement for the MYNX CONTROL VENOUS closure device.Source
  • 13

    Cordis is hiring an AI and automation developer to build "copilots" and "knowledge-enabled solutions" with human oversight. Reps and specialists are asked technical questions in the cath lab every day across a large catalogue.

    High impactMedium effort First result in 2 quarters Applications Developer II

    First action

    Collect 50 real field questions.

    How to measure it

    Answers with a cited source

    Now
    –
    Target
    95%
    By
    2 quarters

    Steps

    1. 1

      Collect questions

      50 from the field.

      Senior Sales Trainer 2 weeks

    2. 2

      Load sources

      IFUs, SKUs, guides.

      Applications Developer II, AI & Automation 1 month

    3. 3

      Set guardrails

      Escalate off-label.

      Regulatory Affairs and Legal 2 weeks

    4. 4

      Pilot

      Ten field users.

      Applications Developer II, AI & Automation 1 month

    5. 5

      Review answers

      Medical Information.

      Medical Information weekly

    6. 6

      Roll out

      All U.S. field.

      Applications Developer II, AI & Automation 1 quarter

    First result
    2 quarters
    Cost
    Development time
    Owner
    Applications Developer II, AI & Automation

    Smallest test

    Test the assistant on 50 questions.

    Why it works

    Build an internal assistant that answers only from IFUs, SKU tables, approved claims and reimbursement guides, cites the source, and escalates anything off-label to Medical Information.

    Faster, consistent answers help new hires and reduce off-label risk.

    Risks and how to handle them

    • Wrong answers

      Answer only with citations; escalate the rest.

    Evidence

    • HiringApplications Developer II, AI & Automation (remote, posted September 18, 2026): build "AI-assisted workflows, copilots, conversational experiences, agents, and knowledge-enabled solutions" with Airtable, Power Platform and AI platforms, with "human oversight, exception handling, and escalation paths".Source
    • Your websiteSELUTION SLR PTCA product page: MicroReservoir and phospholipid coating explained, "36% less force to deliver compared to AGENT DCB" (Cordis 2025 data on file), a sortable SKU table, and links for questions, reimbursement, trials and education. Its meta description is the same company boilerplate used across the site ("Cordis is a global leader in delivering innovative, differentiated cardiovascular and endovascular devices...") and the page has no canonical tag.Source
    • Your websiteSELUTION SLR reimbursement page: coding and payment guidance, two downloadable coding guides, a Reimbursement Support Team phone line, and a Cordis Patient Access Program offering benefits verification and prior authorization support.Source
    • HiringU.S. field hiring since September 21, 2026: Territory Managers (Syracuse, Albany, Northwest Atlanta, Memphis) for "Cold calling, prospecting"; Clinical Sales Specialists (Columbia SC, Greenville/Spartanburg, Sarasota, Chattanooga) focused on "the cultivation of new physician users and re-engaging lost customers"; and a Senior Sales Trainer for "new product introductions, portfolio expansions".Source
  • 14

    Real visitors pass Core Web Vitals, but the Chrome UX Report shows load time trending 14% slower, and PageSpeed estimates 1.5s saved by setting efficient cache lifetimes on 541 KB of files.

    Medium impactLow effort First result in 1 month Specialist II Digital Marketi…

    First action

    Add cache headers to static files.

    How to measure it

    75th percentile LCP

    Now
    –
    Target
    under 2.0s
    By
    60 days

    Steps

    1. 1

      Audit headers

      Static files.

      Specialist II Digital Marketing 1 day

    2. 2

      Set caching

      Versioned assets.

      IT 2 days

    3. 3

      Defer tags

      Non-essential scripts.

      Specialist II Digital Marketing 2 days

    4. 4

      Retest

      PageSpeed.

      Specialist II Digital Marketing 1 day

    5. 5

      Monitor

      Chrome UX Report.

      Specialist II Digital Marketing monthly

    6. 6

      Report

      To marketing.

      Specialist II Digital Marketing quarterly

    First result
    1 month
    Cost
    $0
    Owner
    Specialist II Digital Marketing

    Smallest test

    Set caching on fonts first.

    Why it works

    Set long cache headers for versioned scripts, styles and fonts, defer the tag manager where possible and recheck the mobile test.

    Most visitors are busy clinicians on hospital networks and phones; keeping pages fast protects the passing score.

    Risks and how to handle them

    • Stale files after updates

      Use versioned file names.

    Evidence

    • Google PageSpeedMobile test of the North America site: performance 89, largest content 2.8s in the lab (target 2.5s), but real visitors pass Core Web Vitals (field LCP 2.1s, INP 93ms). The Chrome UX Report shows load time trending 14% slower. Biggest fix: efficient cache lifetimes (about 1.5s, 541 KB).Source
  • 15

    Cordis@hand is rated 4.91 by its users but has not been updated since March 2022, before the drug-eluting balloon portfolio arrived. An app that looks abandoned undermines a launch message about innovation.

    Medium impactLow effort First result in 1 quarter Director

    First action

    Check active users of the app.

    How to measure it

    Outdated app versions in stores

    Now
    –
    Target
    0
    By
    1 quarter

    Steps

    1. 1

      Check usage

      Active users and content.

      Specialist II Digital Marketing 1 week

    2. 2

      Decide

      Update or retire.

      Director, Medical Education 1 week

    3. 3

      Update content

      If kept.

      Specialist II Digital Marketing 1 month

    4. 4

      Retire

      If not, with a message to users.

      Specialist II Digital Marketing 2 weeks

    5. 5

      Redirect

      To LUMEN and the site.

      Specialist II Digital Marketing 1 day

    6. 6

      Review

      Yearly.

      Specialist II Digital Marketing yearly

    First result
    1 quarter
    Cost
    Small
    Owner
    Director, Medical Education

    Smallest test

    Pull the app's active user count.

    Why it works

    Decide in one review: update it with SELUTION, current IFUs and the LUMEN link, or retire it and redirect users to the mobile site and LUMEN.

    Either choice removes an outdated touchpoint that existing users trust.

    Risks and how to handle them

    • Losing loyal users

      Message them before retiring.

    Evidence

    • App StoreThe Cordis@hand iOS app is rated 4.91 from 35 ratings but was last updated on March 22, 2022.Source
    • Your websiteMedical Education page: hands-on MYNX Elevate and MYNX Masters courses for cath and EP lab staff ("up to 4 CE credits"), each with "Request Additional Information", and LUMEN BY CORDIS, an online learning platform "currently available to US based physicians only".Source
    • Your websiteFDA approval news (September 21, 2026): SELUTION SLR DEB is approved for coronary in-stent restenosis (ISR) and is "the first and only sirolimus drug-eluting balloon approved in the United States". SELUTION4ISR enrolled more than 400 patients at 48 sites; "nearly 1 million" PCIs a year in the U.S., about 10% for ISR; SELUTION4DeNovo (960 patients, small vessels) has completed enrollment. Cordis introduced the first sirolimus drug-eluting stent in the U.S. in 2003.Source

Big bets 3

Larger plays that can change the trajectory.

  • 16

    Cordis launched a global coronary registry for SELUTION SLR that will enroll up to 10,000 patients. Real-world data is what late adopters wait for.

    High impactHigh effort First result in 3 quarters Senior Manager

    First action

    Agree the publication plan with Medical Affairs.

    How to measure it

    Registry summaries published

    Now
    –
    Target
    2 a year
    By
    4 quarters

    Steps

    1. 1

      Plan

      Publication and congress schedule.

      Senior Manager, Product Marketing 1 month

    2. 2

      Govern

      Data review process.

      Regulatory Affairs and Legal 1 month

    3. 3

      Build

      Dashboard page.

      Specialist II Digital Marketing 1 month

    4. 4

      Publish

      First summary.

      Senior Manager, Product Marketing 1 quarter

    5. 5

      Present

      At congresses.

      Senior Manager, Product Marketing per congress

    6. 6

      Update

      Each data cut.

      Senior Manager, Product Marketing semi-annual

    First result
    3 quarters
    Cost
    Analysis and publication costs
    Owner
    Senior Manager, Product Marketing

    Smallest test

    Publish enrollment progress only.

    Why it works

    With Medical Affairs, publish periodic, peer-reviewed registry summaries on the evidence hub (enrollment, lesion types, outcomes when available) and present them at each major congress.

    A visible, growing real-world dataset answers the "show me it works in practice" objection and keeps Cordis in the news cycle between trials.

    Risks and how to handle them

    • Interim data misread

      Label interim results and follow publication rules.

    Evidence

    • Your websiteClinical information page for drug-eluting balloons: a trial table (indication, patients, region, design, status, ClinicalTrials.gov number, results), for example SELUTION4SFA, 300 patients, 2:1 RCT DEB vs PTA, NCT05132361. News from May 2025: a global coronary registry for SELUTION SLR "will enroll up to 10,000 patients worldwide".Source
    • Your websiteFDA approval news (September 21, 2026): SELUTION SLR DEB is approved for coronary in-stent restenosis (ISR) and is "the first and only sirolimus drug-eluting balloon approved in the United States". SELUTION4ISR enrolled more than 400 patients at 48 sites; "nearly 1 million" PCIs a year in the U.S., about 10% for ISR; SELUTION4DeNovo (960 patients, small vessels) has completed enrollment. Cordis introduced the first sirolimus drug-eluting stent in the U.S. in 2003.Source
    • HiringSenior Manager, Product Marketing (remote, posted October 1, 2026): translate "approved clinical evidence into clear, differentiated commercial positioning", create "evidence summaries, data-driven messaging tools, congress materials, field-facing resources", lead symposia and congress programs, and support the field with "objection handling, and competitive response materials".Source
  • 17

    The Senior Manager, Medical Education job asks for faculty and programs "for future technologies (IVL, Carotid, Peripheral) from pre-launch to post market". Shockwave Medical builds its business around IVL, so Cordis will enter that category against an established specialist, and faculty depth will matter.

    High impactHigh effort First result in 4 quarters Senior Manager

    First action

    List physicians already active in Cordis programs.

    How to measure it

    Certified faculty

    Now
    –
    Target
    25 per therapy
    By
    4 quarters

    Steps

    1. 1

      Map physicians

      Trial and course faculty.

      Senior Manager, Medical Education 1 month

    2. 2

      Design program

      Training and proctoring.

      Senior Manager, Medical Education 1 month

    3. 3

      Compliance

      Fair-market-value contracts.

      Regulatory Affairs and Legal 1 month

    4. 4

      Recruit

      Invite faculty.

      Manager, Medical Education 1 quarter

    5. 5

      Train

      Certification.

      Manager, Medical Education 2 quarters

    6. 6

      Launch courses

      After clearance.

      Senior Manager, Medical Education per launch

    First result
    4 quarters
    Cost
    Faculty fees under fair-market value
    Owner
    Senior Manager, Medical Education

    Smallest test

    Invite five physicians to a faculty planning call.

    Why it works

    Map the physicians already working with Cordis on SELUTION4SFA, carotid courses and radial programs, invite them into a faculty program with training and proctor certification, and plan courses that start once each product is cleared.

    Peer educators ready on approval day shorten adoption in competitive categories.

    Risks and how to handle them

    • Pre-approval promotion

      No promotion of uncleared devices; education only after clearance.

    Evidence

    • HiringMedical education hiring: a Manager, Medical Education (posted October 16, 2026) to run "workshops, proctoring pathways, virtual learning, symposia" and track programs with "defined KPIs"; a Senior Manager, Medical Education to "Create the universal framework for program analytics", "Develop end to end strategy supporting Medical Education digital marketing" and build faculty "for future technologies (IVL, Carotid, Peripheral) from pre-launch to post market".Source
    • Competitor researchRivals' own homepages: Shockwave Medical, "From IVL to coronary sinus reduction"; Terumo Interventional Systems, devices "for interventional cardiology, interventional radiology and vascular surgery". Cordis's own SELUTION page benchmarks against Boston Scientific's AGENT DCB.Source
    • Your websiteNews (October 6, 2026): SELUTION SLR SUSTANE PTA DEB reached 90.3% 12-month primary patency in the 300-patient SELUTION4SFA U.S. pivotal trial, presented at VIVA 2026; the trial "supports the SUSTANE DEB FDA submission".Source
  • 18

    Cordis plans to invest about $60 million in Miami Lakes and create up to 300 jobs, and its job board lists many manufacturing roles there on three shifts.

    Medium impactMedium effort First result in 2 quarters Chief Human Resources Officer

    First action

    Build one Miami Lakes careers page.

    How to measure it

    Time to fill Miami Lakes roles

    Now
    –
    Target
    -30%
    By
    4 quarters

    Steps

    1. 1

      Page

      Miami Lakes careers.

      Talent Acquisition 2 weeks

    2. 2

      Partners

      Local colleges and programs.

      Talent Acquisition 1 quarter

    3. 3

      Stories

      Employee features.

      Specialist II Digital Marketing monthly

    4. 4

      Events

      Hiring days.

      Talent Acquisition quarterly

    5. 5

      Track

      Time to fill.

      Talent Acquisition monthly

    6. 6

      Share

      With press.

      Communications quarterly

    First result
    2 quarters
    Cost
    Recruiting budget
    Owner
    Chief Human Resources Officer

    Smallest test

    Publish the careers page.

    Why it works

    Create a Miami Lakes careers page with shift roles, pay ranges and training paths, run local partnerships with colleges, and publish short stories of the people who make SELUTION and other devices.

    Filling manufacturing roles fast protects launch supply, and a local story gives press and hospitals a human reason to remember Cordis.

    Risks and how to handle them

    • Hiring outpaces training

      Pair hires with training cohorts.

    Evidence

    • Your websiteNews (March 17, 2026): Cordis plans to invest about $60 million at its Miami Lakes headquarters, "supporting the creation of up to 300 new full-time jobs", backed by a State of Florida grant.Source
    • Your websiteFDA approval news (September 21, 2026): SELUTION SLR DEB is approved for coronary in-stent restenosis (ISR) and is "the first and only sirolimus drug-eluting balloon approved in the United States". SELUTION4ISR enrolled more than 400 patients at 48 sites; "nearly 1 million" PCIs a year in the U.S., about 10% for ISR; SELUTION4DeNovo (960 patients, small vessels) has completed enrollment. Cordis introduced the first sirolimus drug-eluting stent in the U.S. in 2003.Source

Wildcards 3

Unexpected experiments, each with a cheap way to test it.

  • 19

    Cordis introduced the first sirolimus drug-eluting stent in the U.S. in 2003 and now the first sirolimus DEB. The TCT page already calls this "the Limus Era".

    Medium impactLow effort First result in 1 quarter Senior Manager

    First action

    Interview two physicians who used both devices.

    How to measure it

    Video views from physicians

    Now
    –
    Target
    10,000
    By
    2 quarters

    Steps

    1. 1

      Script

      Two decades in five minutes.

      Senior Manager, Product Marketing 2 weeks

    2. 2

      Interview

      Physicians.

      Manager, Medical Education 1 month

    3. 3

      Produce

      Video and page.

      Specialist II Digital Marketing 1 month

    4. 4

      Review

      Claims.

      Regulatory Affairs and Legal 2 weeks

    5. 5

      Publish

      Site, YouTube, LinkedIn.

      Specialist II Digital Marketing 1 week

    6. 6

      Measure

      Views and requests.

      Specialist II Digital Marketing monthly

    First result
    1 quarter
    Cost
    Production costs
    Owner
    Senior Manager, Product Marketing

    Smallest test

    Post one LinkedIn piece on the 2003 milestone.

    Why it works

    Make a short heritage series (video, page, LinkedIn posts) on two decades of sirolimus work, with physicians who used both devices, linking to the evidence hub.

    Heritage gives a new device credibility, and few rivals can tell the same story.

    Risks and how to handle them

    • Confusing stent and balloon claims

      Keep indications separate and clear.

    Evidence

    • Your websiteFDA approval news (September 21, 2026): SELUTION SLR DEB is approved for coronary in-stent restenosis (ISR) and is "the first and only sirolimus drug-eluting balloon approved in the United States". SELUTION4ISR enrolled more than 400 patients at 48 sites; "nearly 1 million" PCIs a year in the U.S., about 10% for ISR; SELUTION4DeNovo (960 patients, small vessels) has completed enrollment. Cordis introduced the first sirolimus drug-eluting stent in the U.S. in 2003.Source
    • Your websiteTCT 2026 page: "Welcome to the Limus Era", "The Drug. The Data. The Delivery.", a symposium "Delivering Limus Differently", a reception, and a "Next-Generation DEB Decision Lab", "an interactive, case-based experience focused on the key clinical and technical decision points in DEB therapy". The call to action is "Request Additional Information".Source
    • Your websiteAbout page: "nearly 70 years" of firsts, growth through "internal development, Cordis-X partnerships, and strategic acquisitions"; the investor partner text still describes Hellman & Friedman's assets "as of September 30, 2021".Source
  • 20

    The About page still describes the investor partner's assets "as of September 30, 2021", and the root cordis.com shows only a country list.

    Low impactLow effort First result in 2 weeks Communications

    First action

    Update the investor paragraph.

    How to measure it

    About page facts older than a year

    Now
    –
    Target
    0
    By
    30 days

    Steps

    1. 1

      Rewrite

      Investor and milestone text.

      Communications 2 days

    2. 2

      Root page

      Brand line above the picker.

      Specialist II Digital Marketing 2 days

    3. 3

      Review

      Legal.

      Regulatory Affairs and Legal 2 days

    4. 4

      Publish

      Both pages.

      Specialist II Digital Marketing 1 day

    5. 5

      Check

      Previews and search.

      Specialist II Digital Marketing 1 day

    6. 6

      Repeat

      Twice a year.

      Communications 6 months

    First result
    2 weeks
    Cost
    $0
    Owner
    Communications

    Smallest test

    Update the investor paragraph today.

    Why it works

    Update investor text, add the SELUTION milestones, the Miami Lakes investment and Cordis-X, and give the root page a short brand statement above the country picker.

    Hospital buyers and journalists check About pages; current facts signal momentum.

    Risks and how to handle them

    • Investor approvals

      Use their own current descriptions.

    Evidence

    • Your websiteAbout page: "nearly 70 years" of firsts, growth through "internal development, Cordis-X partnerships, and strategic acquisitions"; the investor partner text still describes Hellman & Friedman's assets "as of September 30, 2021".Source
    • Your websitecordis.com itself is a country picker titled "Welcome to Cordis" with about 200 country links and no product or company content; the North America home is at /na/home and has no canonical tag. Google PageSpeed names the country list as the page's layout-shift element.Source
    • Your websiteNews (March 17, 2026): Cordis plans to invest about $60 million at its Miami Lakes headquarters, "supporting the creation of up to 300 new full-time jobs", backed by a State of Florida grant.Source
  • 21

    The root domain is a list of about 200 countries; PageSpeed flags it as the layout-shift element. Visitors and search engines see no product or news before choosing a region.

    Medium impactMedium effort First result in 1 quarter Specialist II Digital Marketi…

    First action

    Add a suggested region button.

    How to measure it

    Root page exits

    Now
    –
    Target
    -30%
    By
    1 quarter

    Steps

    1. 1

      Suggest region

      Based on location.

      Specialist II Digital Marketing 1 week

    2. 2

      Add message

      Company and news line.

      Communications 2 days

    3. 3

      Fix layout

      No shift.

      Specialist II Digital Marketing 2 days

    4. 4

      Review

      Regional regulatory needs.

      Regulatory Affairs and Legal 1 week

    5. 5

      Publish

      Root page.

      Specialist II Digital Marketing 1 day

    6. 6

      Measure

      Exits and region choice.

      Specialist II Digital Marketing monthly

    First result
    1 quarter
    Cost
    Development time
    Owner
    Specialist II Digital Marketing

    Smallest test

    Add the suggested region button.

    Why it works

    Detect location to suggest a region, show a single line on the company with the latest approval, and keep the full list one click away.

    It gives the strongest domain a purpose for search and links, and saves visitors a step.

    Risks and how to handle them

    • Regional rules

      Keep product claims out of the root page.

    Evidence

    • Your websitecordis.com itself is a country picker titled "Welcome to Cordis" with about 200 country links and no product or company content; the North America home is at /na/home and has no canonical tag. Google PageSpeed names the country list as the page's layout-shift element.Source
    • Google PageSpeedMobile test of the North America site: performance 89, largest content 2.8s in the lab (target 2.5s), but real visitors pass Core Web Vitals (field LCP 2.1s, INP 93ms). The Chrome UX Report shows load time trending 14% slower. Biggest fix: efficient cache lifetimes (about 1.5s, 541 KB).Source
    • Your websiteFDA approval news (September 21, 2026): SELUTION SLR DEB is approved for coronary in-stent restenosis (ISR) and is "the first and only sirolimus drug-eluting balloon approved in the United States". SELUTION4ISR enrolled more than 400 patients at 48 sites; "nearly 1 million" PCIs a year in the U.S., about 10% for ISR; SELUTION4DeNovo (960 patients, small vessels) has completed enrollment. Cordis introduced the first sirolimus drug-eluting stent in the U.S. in 2003.Source
More example playbooks and reviews

More growth playbooks

Other companies we have researched, each read from what they are hiring for.

  • Paddle growth strategyA merchant of record for software, AI and app companies: checkout, subscriptions, payments, global sales tax and compliance, fraud…21 growth ideas
  • Portalcrafter growth strategyA no-code studio that builds custom client portals, internal tools, CRMs, marketplaces and MVPs on Softr and Airtable, with Make and…22 growth ideas
  • Teleport growth strategyAn infrastructure identity platform that gives every human, machine, workload and AI agent a cryptographic identity with short-lived…22 growth ideas
  • NewForm growth strategyPerformance creative for paid social: Framework creative analytics and testing software, the NewForm One managed creator program, and…20 growth ideas
  • RapidDev growth strategyAn AI consulting and software development agency (Rapid Developers LLC) that builds AI agents, automations, custom web and mobile apps and…23 growth ideas
  • Lab0 growth strategyAI agents (an "AI forward-deployed engineer") that run enterprise software implementations: discovery, configuration, integration, testing…23 growth ideas
  • Bayesian Health growth strategyA real-time clinical intelligence platform inside the EHR that monitors every patient and flags those at risk, with an FDA-cleared…21 growth ideas
  • Preggy Plus growth strategyA baby and family store in Trinidad and Tobago (Preggy Plus Limited) selling gear, furniture, feeding, toys and clothing online and from a…22 growth ideas

See every playbook and website review

Independent research. Programmable wrote this playbook from public sources, as they stood on October 21, 2026, and cites them throughout. Cordis did not commission, review or endorse it, and Programmable is not affiliated with Cordis. Company and product names are trademarks of their owners, used only to identify them. The ideas are suggestions and opinion, not professional, legal or financial advice, and not statements about how Cordis runs its business.

Something wrong, or do you represent Cordis? Email [email protected] and we will correct it or take it down.

30/60/90 roadmap

What to focus on in each month, and the ideas that carry it.

  1. Days 1 to 307 ideas

    Remove the placeholder case studies and publish real ones, write product descriptions, fix the events page, start the VAC pack, route information requests and clean up test pages; refresh About.

  2. Days 31 to 6011 ideas

    Evidence hub, online DEB Decision Lab, education analytics, launch certification, lost-account lists, rebate tiers, the field assistant, caching and the app decision; the sirolimus heritage series and the root page.

  3. Days 61 to 903 ideas

    Commit to the registry dashboard, the future-therapy faculty network and Miami Lakes recruiting.

The research behind the plan

3 research areas, each summarised in a few lines. Open any of them for the full detail.

Customers

What customers say

Customers value deliverable, well-known device brands. The most cited problem: repeat procedures for in-stent restenosis.

  • Hands-on education with CE credits
  • Adding metal layers with each new stent
  • In their words: “leave nothing behind”

Market

Competitive landscape

3 competitors compared: Boston Scientific, Shockwave Medical and Terumo Interventional Systems.

  • Gap to exploit: Sirolimus DEB education for U.S. physicians
  • Boston Scientific: Cordis claims SELUTION needs 36% less force to deliver than AGENT (data on file)
  • Shockwave Medical: Narrower portfolio

Hiring signals

Cordis is staffing the SELUTION SLR launch.

  • Senior Manager, Product Marketing: Evidence into positioning and congress programs. Ideas 1, 4, 7.
  • Senior Manager, Medical Education: Program analytics and future-therapy faculty. Ideas 8, 9, 17.
  • Manager, Medical Education: Workshops, proctoring and virtual learning. Ideas 1, 3, 8.

From the team that wrote this playbook

All products
  • ProgrammableAgencyWorking AI systems in days, not quarters (opens programmable.agency in a new tab)
  • ProgrammableInfoAn agent that finds, researches and asks firstNew accounts get 100,000 free enrichment credits with code BETA100K (opens programmable.info in a new tab)
  • ProgrammableDigitalScreenshots in, an animated product demo out (opens programmable.digital in a new tab)
  • ProgrammableWatchKnow the day a supplier falls out of compliance (opens programmable.watch in a new tab)
  • ProgrammableTalkGet registrants for your events, and know who’s coming (opens programmable.talk in a new tab)
  • ProgrammableMediaAn AI note taker, interpreter and webinar host for your calls (opens programmable.media in a new tab)
  • ProgrammablePageText what you need, your customer gets a page that works (opens programmable.page in a new tab)
  • ProgrammableCommunityForums with labelled AI members, never empty (opens programmable.community in a new tab)
ProgrammableMarketing
ExamplesLeaderboardsProductsTermsPrivacyCookiesDPALegalContact

© 2026 AI-Powered Growth Intelligence